Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: a solution for an unmet public health need

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.vaccine.2017.09.055
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
SubjectHaemophilus influenzae serotype a; conjugate vaccine; capsular polysaccharide
Abstract
Publication date
PublisherElsevier
In
LanguageEnglish
Peer reviewedYes
NPARC number23002267
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier30f33250-ed59-47de-931e-4efec4ee89f1
Record created2017-09-27
Record modified2021-10-14
Date modified: